P15382 (KCNE1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 142.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Potassium voltage-gated channel subfamily E member 1 Alternative name(s): Delayed rectifier potassium channel subunit IsK IKs producing slow voltage-gated potassium channel subunit beta Mink Minimal potassium channel | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 129 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Ancillary protein that assembles as a beta subunit with a voltage-gated potassium channel complex of pore-forming alpha subunits. Modulates the gating kinetics and enhances stability of the channel complex. Assembled with KCNQ1/KVLQT1 is proposed to form the slowly activating delayed rectifier cardiac potassium (IKs) channel. The outward current reaches its steady state only after 50 seconds. Assembled with KCNH2/HERG may modulate the rapidly activating component of the delayed rectifying potassium current in heart (IKr). |
| Subunit structure | Associates with KCNQ1/KVLQT1 and KCNH2/HERG. |
| Subcellular location | |
| Tissue specificity | Expressed in heart, lung, kidney, testis, ovaries, small intestine, peripheral blood leukocytes. Not detected in pancreas, spleen, prostate and colon. Restrictively localized in the apical membrane portion of epithelial cells. Ref.6 |
| Post-translational modification | Phosphorylation inhibits the potassium current By similarity. N-glycosylation at Asn-26 occurs post-translationally, and requires prior cotranslational glycosylation at Asn-5. |
| Involvement in disease | Jervell and Lange-Nielsen syndrome 2 (JLNS2) [MIM:612347]: An autosomal recessive disorder characterized by congenital deafness, prolongation of the QT interval, syncopal attacks due to ventricular arrhythmias, and a high risk of sudden death. Long QT syndrome 5 (LQT5) [MIM:613695]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. |
| Sequence similarities | Belongs to the potassium channel KCNE family. |
| Sequence caution | The sequence AAH36452.1 differs from that shown. Reason: Erroneous termination at position 106. Translated as Cys. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 129 | 129 | Potassium voltage-gated channel subfamily E member 1 | PRO_0000144278 | |||||||||||||||||||||
Regions | |||||||||||||||||||||||||
| Transmembrane | 44 – 66 | 23 | Helical; Potential | ||||||||||||||||||||||
| Topological domain | 67 – 129 | 63 | Cytoplasmic Potential | ||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||
| Modified residue | 102 | 1 | Phosphoserine; by PKC By similarity | ||||||||||||||||||||||
| Glycosylation | 5 | 1 | N-linked (GlcNAc...) Ref.9 Ref.10 | ||||||||||||||||||||||
| Glycosylation | 7 | 1 | O-linked (GalNAc...) Ref.10 | ||||||||||||||||||||||
| Glycosylation | 26 | 1 | N-linked (GlcNAc...) Ref.9 | ||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||
| Natural variant | 7 | 1 | T → I in JLNS2; impairs glycosylation at N-5. Ref.9 Ref.14 Corresponds to variant rs28933384 [ dbSNP | Ensembl ]. | VAR_008897 | |||||||||||||||||||||
| Natural variant | 32 | 1 | R → H in LQT5; uncertain pathological significance. Ref.5 Ref.18 Corresponds to variant rs17857111 [ dbSNP | Ensembl ]. | VAR_009906 | |||||||||||||||||||||
| Natural variant | 38 | 1 | S → G. Ref.2 Ref.5 Ref.21 Corresponds to variants rs17846179 [ dbSNP | Ensembl ] and rs1805127 [ dbSNP | Ensembl ]. | VAR_001558 | |||||||||||||||||||||
| Natural variant | 47 | 1 | V → F in JLNS2. Ref.17 | VAR_008898 | |||||||||||||||||||||
| Natural variant | 51 | 1 | L → H in JLNS2. Ref.17 | VAR_008899 | |||||||||||||||||||||
| Natural variant | 52 | 1 | G → A. Corresponds to variant rs17173509 [ dbSNP | Ensembl ]. | VAR_048024 | |||||||||||||||||||||
| Natural variant | 58 – 59 | 2 | TL → PP in JLNS2. | VAR_001559 | |||||||||||||||||||||
| Natural variant | 74 | 1 | S → L in LQT5. Ref.15 | VAR_008900 | |||||||||||||||||||||
| Natural variant | 76 | 1 | D → N in LQT5 and JLNS2; suppresses KCNQ1 currents markedly. Ref.14 Ref.15 Ref.16 Ref.17 | VAR_008901 | |||||||||||||||||||||
| Natural variant | 85 | 1 | D → N Predisposes to acquired LQT5 susceptibility; shows a significant difference in current density and midpoint potential between the mutant and the wildt-ype channels. Ref.12 Ref.20 Ref.21 Corresponds to variant rs1805128 [ dbSNP | Ensembl ]. | VAR_008902 | |||||||||||||||||||||
| Natural variant | 87 | 1 | W → R in LQT5. Ref.17 | VAR_008903 | |||||||||||||||||||||
| Natural variant | 98 | 1 | R → W in LQT5. Ref.18 | VAR_009907 | |||||||||||||||||||||
| Natural variant | 109 | 1 | V → I in LQT5; mild phenotype; significantly reduced the wild-type I(KS) current amplitude. Ref.19 | VAR_012802 | |||||||||||||||||||||
| Natural variant | 127 | 1 | P → T in LQT5. Ref.18 | VAR_009908 | |||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||
| Mutagenesis | 5 | 1 | N → Q: No measurable effect on assembly with KCNQ1 or cell surface expression of the KCNE1/KCNQ1 channel complex, and loss of glycosylation at N-5; when associated with T-28. Ref.10 | ||||||||||||||||||||||
| Mutagenesis | 6 | 1 | T → F: No measurable effect on assembly with KCNQ1 or cell surface expression of the KCNE1/KCNQ1 channel complex. Loss of glycosylation at T-7. Ref.10 | ||||||||||||||||||||||
| Mutagenesis | 7 | 1 | T → A: 50% reduction of cell surface expression of the KCNE1/KCNQ1 channel complex, and loss of glycosylation at N-5 and T-7; when associated with T-28. Ref.10 | ||||||||||||||||||||||
| Mutagenesis | 28 | 1 | S → T: No measurable effect on assembly with KCNQ1 or cell surface expression of the KCNE1/KCNQ1 channel complex, and loss of glycosylation at N-5; when associated with Q-5. 50% reduction of cell surface expression of the KCNE1/KCNQ1 channel complex, and loss of glycosylation at N-5 and T-7; when associated with A-7. Ref.10 | ||||||||||||||||||||||
| Mutagenesis | 69 | 1 | K → H: Lowers current 2-fold and leads to faster deactivation of KCNQ1/KCNE1 channel. Ref.8 | ||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||
| Helix | 4 – 9 | 6 | |||||||||||||||||||||||
| Helix | 13 – 22 | 10 | |||||||||||||||||||||||
| Helix | 30 – 32 | 3 | |||||||||||||||||||||||
| Helix | 46 – 71 | 26 | |||||||||||||||||||||||
| Turn | 77 – 81 | 5 | |||||||||||||||||||||||
| Turn | 84 – 86 | 3 | |||||||||||||||||||||||
| Helix | 92 – 105 | 14 | |||||||||||||||||||||||
| Beta strand | 114 – 116 | 3 | |||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning and sequence analysis of human genomic DNA encoding a novel membrane protein which exhibits a slowly activating potassium channel activity." Murai T., Kakizuka A., Takumi T., Ohkubo H., Nakanishi S. Biochem. Biophys. Res. Commun. 161:176-181(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Polymorphism of the gene encoding a human minimal potassium ion channel (minK)." Lai L.P., Deng C.L., Moss A.J., Kass R.S., Liang C.S. Gene 151:339-340(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT GLY-38. Tissue: Leukocyte. |
| [3] | "Delayed rectifier potassium channel subunit from human cornea epithelium." Rae J.L. Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Cornea. |
| [4] | NHLBI resequencing and genotyping service (RS&G) Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANTS HIS-32 AND GLY-38. Tissue: Testis. |
| [6] | "Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias." Chouabe C., Neyroud N., Guicheney P., Lazdunski M., Romey G., Barhanin J. EMBO J. 16:5472-5479(1997) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [7] | "A minK-HERG complex regulates the cardiac potassium current I(Kr)." McDonald T.V., Yu Z., Ming Z., Palma E., Meyers M.B., Wang K.-W., Goldstein S.A.N., Fishman G.I. Nature 388:289-292(1997) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH KCNH2. |
| [8] | "Disease-associated mutations in KCNE potassium channel subunits (MiRPs) reveal promiscuous disruption of multiple currents and conservation of mechanism." Abbott G.W., Goldstein S.A.N. FASEB J. 16:390-400(2002) [PubMed] [Europe PMC] [Abstract] Cited for: MUTAGENESIS OF LYS-69. |
| [9] | "Post-translational N-glycosylation of type I transmembrane KCNE1 peptides: implications for membrane protein biogenesis and disease." Bas T., Gao G.Y., Lvov A., Chandrasekhar K.D., Gilmore R., Kobertz W.R. J. Biol. Chem. 286:28150-28159(2011) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION AT ASN-5 AND ASN-26, CHARACTERIZATION OF VARIANT JLNS2 ILE-7. |
| [10] | "O-glycosylation of the cardiac I(Ks) complex." Chandrasekhar K.D., Lvov A., Terrenoire C., Gao G.Y., Kass R.S., Kobertz W.R. J. Physiol. (Lond.) 589:3721-3730(2011) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION AT ASN-5 AND THR-7, MUTAGENESIS OF ASN-5; THR-6; THR-7 AND SER-28. |
| [11] | "Structure of KCNE1 and implications for how it modulates the KCNQ1 potassium channel." Kang C., Tian C., Soennichsen F.D., Smith J.A., Meiler J., George A.L. Jr., Vanoye C.G., Kim H.J., Sanders C.R. Biochemistry 47:7999-8006(2008) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR. |
| [12] | "Exclusion of KCNE1 (IsK) as a candidate gene for Jervell and Lange-Nielsen syndrome." Tesson F., Donger C., Denjoy I., Berthet M., Bennaceur M., Petit C., Coumel P., Schwartz K., Guicheney P. J. Mol. Cell. Cardiol. 28:2051-2055(1996) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ASN-85. |
| [13] | "IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome." Tyson J., Tranebjaerg L., Bellman S., Wren C., Taylor J.F.N., Bathen J., Aslaksen B., Soerland S.J., Lund O., Malcolm S., Pembrey M., Bhattacharya S., Bitner-Glindzicz M. Hum. Mol. Genet. 6:2179-2185(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT JLNS2 58-PRO-PRO-59. |
| [14] | "KCNE1 mutations cause Jervell and Lange-Nielsen syndrome." Schulze-Bahr E., Wang Q., Wedekind H., Haverkamp W., Chen Q., Sun Y., Rubie C., Hordt M., Towbin J.A., Borggrefe M., Assmann G., Qu X., Somberg J.C., Breithardt G., Oberti C., Funke H. Nat. Genet. 17:267-268(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS JLNS2 ILE-7 AND ASN-76. |
| [15] | "Mutations in the hminK gene cause long QT syndrome and suppress IKs function." Splawski I., Tristani-Firouzi M., Lehmann M.H., Sanguinetti M.C., Keating M.T. Nat. Genet. 17:338-340(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS LQT5 LEU-74 AND ASN-76. |
| [16] | "Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome." Duggal P., Vesely M.R., Wattanasirichaigoon D., Villafane J., Kaushik V., Beggs A.H. Circulation 97:142-146(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT LQT5 ASN-76. |
| [17] | "Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome." Bianchi L., Shen Z., Dennis A.T., Priori S.G., Napolitano C., Ronchetti E., Bryskin R., Schwartz P.J., Brown A.M. Hum. Mol. Genet. 8:1499-1507(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS JLNS2 PHE-47; HIS-51 AND ASN-76, VARIANT LQT5 ARG-87. |
| [18] | "Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2." Splawski I., Shen J., Timothy K.W., Lehmann M.H., Priori S.G., Robinson J.L., Moss A.J., Schwartz P.J., Towbin J.A., Vincent G.M., Keating M.T. Circulation 102:1178-1185(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS LQT5 HIS-32; TRP-98 AND THR-127. |
| [19] | "A novel long-QT 5 gene mutation in the C-terminus (V109I) is associated with a mild phenotype." Schulze-Bahr E., Schwarz M., Hauenschild S., Wedekind H., Funke H., Haverkamp W., Breithardt W., Pongs O., Isbrandt D., Breithardt G. J. Mol. Med. 79:504-509(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT LQT5 ILE-109. |
| [20] | "Compound mutations: a common cause of severe long-QT syndrome." Westenskow P., Splawski I., Timothy K.W., Keating M.T., Sanguinetti M.C. Circulation 109:1834-1841(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ASN-85. |
| [21] | "The contribution of genes involved in potassium-recycling in the inner ear to noise-induced hearing loss." Van Laer L., Carlsson P.-I., Ottschytsch N., Bondeson M.-L., Konings A., Vandevelde A., Dieltjens N., Fransen E., Snyders D., Borg E., Raes A., Van Camp G. Hum. Mutat. 27:786-795(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GLY-38 AND ASN-85, CHARACTERIZATION OF VARIANT ASN-85. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M26685 Genomic DNA. Translation: AAA36129.1. L33815 Genomic DNA. Translation: AAA63905.1. L28168 mRNA. Translation: AAA58418.1. AF135188 mRNA. Translation: AAD25096.1. DQ784803 Genomic DNA. Translation: ABQ01238.1. BC036452 mRNA. Translation: AAH36452.1. Sequence problems. | ||||||||||||
| IPI | IPI00305022. | ||||||||||||
| PIR | A32447. | ||||||||||||
| RefSeq | NP_000210.2. NM_000219.4. NP_001121140.1. NM_001127668.2. NP_001121141.1. NM_001127669.2. NP_001121142.1. NM_001127670.2. NP_001257331.1. NM_001270402.1. NP_001257332.1. NM_001270403.1. NP_001257333.1. NM_001270404.1. NP_001257334.1. NM_001270405.1. | ||||||||||||
| UniGene | Hs.121495. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P15382. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| STRING | 9606.ENSP00000337255. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P15382. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 116416. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P15382. | ||||||||||||
| PRIDE | P15382. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 3753. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000337385; ENSP00000337255; ENSG00000180509. ENST00000399284; ENSP00000382225; ENSG00000180509. ENST00000399286; ENSP00000382226; ENSG00000180509. ENST00000399289; ENSP00000382228; ENSG00000180509. ENST00000416357; ENSP00000416258; ENSG00000180509. ENST00000432085; ENSP00000412498; ENSG00000180509. | ||||||||||||
| GeneID | 3753. | ||||||||||||
| KEGG | hsa:3753. | ||||||||||||
| UCSC | uc002ytz.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 3753. | ||||||||||||
| GeneCards | GC21M035818. | ||||||||||||
| HGNC | HGNC:6240. KCNE1. | ||||||||||||
| HPA | HPA013752. | ||||||||||||
| MIM | 176261. gene. 612347. phenotype. 613695. phenotype. | ||||||||||||
| neXtProt | NX_P15382. | ||||||||||||
| Orphanet | 334. Familial atrial fibrillation. 90647. Jervell and Lange-Nielsen syndrome. 101016. Romano-Ward syndrome. | ||||||||||||
| PharmGKB | PA211. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG41824. | ||||||||||||
| HOGENOM | HOG000113207. | ||||||||||||
| HOVERGEN | HBG052226. | ||||||||||||
| InParanoid | P15382. | ||||||||||||
| KO | K04894. | ||||||||||||
| OMA | ALYILMV. | ||||||||||||
| OrthoDB | EOG41G35J. | ||||||||||||
| PhylomeDB | P15382. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P15382. | ||||||||||||
| Bgee | P15382. | ||||||||||||
| CleanEx | HS_KCNE1. | ||||||||||||
| Genevestigator | P15382. | ||||||||||||
| GermOnline | ENSG00000180509. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR000369. K_chnl_volt-dep_bsu_KCNE. IPR005424. K_chnl_volt-dep_bsu_KCNE1. [Graphical view] | ||||||||||||
| PANTHER | PTHR17028. PTHR17028. 1 hit. | ||||||||||||
| Pfam | PF02060. ISK_Channel. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR01604. KCNE1CHANNEL. PR00168. KCNECHANNEL. | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | P15382. | ||||||||||||
| ChEMBL | CHEMBL4872. | ||||||||||||
| DrugBank | DB00808. Indapamide. | ||||||||||||
| EvolutionaryTrace | P15382. | ||||||||||||
| GenomeRNAi | 3753. | ||||||||||||
| NextBio | 14697. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | KCNE1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P15382 Secondary accession number(s): A5H1P2, Q8N709, Q91Z94 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 21 Human chromosome 21: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
